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Engineering thermoresponsive polyether-based
nanogels for temperature dependent
skin penetration†
M. Asadian-Birjand,a J. Bergueiro,a F. Rancan,b J. C. Cuggino,a R.-C. Mutihac,a
K. Achazi,a J. Dernedde,c U. Blume-Peytayi,b A. Vogtb and M. Calderón*a
Highly biocompatible thermoresponsive nanogels (tNGs) based on
oligo ethylene glycol (OEG) as thermoresponsive unit and dendritic
polyglycerol (dPG) as cross-linker, were precisely engineered in
terms of size and volume phase transition temperature (VPTT).
Preliminary uptake studies into human skin were realized to
show the temperature-dependent internalization behavior of these
systems.
Transdermal delivery has many advantages in comparison to
intravenous or oral administration like patient amenability,
reduced side eﬀects, and enhanced activity by avoiding hydro-
lytic enzymes or hard environmental/metabolic conditions.1–5
Nonetheless eﬃcient transdermal administration of certain
hydrophilic molecules of biomedical interest (peptides, pro-
teins, hydrophilic drugs, etc.) is still a challenge due to the pro-
tecting barrier function performed by the highly organized
stratum corneum (SC) in the skin.6–9 Several techniques based
on the disruption of the SC’s ordered structure have been
developed, of which microneedles,10 laser ablation11 or ultra-
sound12 are the most commonly used. But all of these tech-
niques present limitations and disadvantages highlighting the
need for a more sophisticated way of action in transdermal
delivery.
Numerous studies suggest that selective skin penetration
and specific targeting eﬀects can be achieved by nanoparticles
with controlled size, lipophilicity, surface charge, and stabi-
lity.13 Recently new soft synthetic, polymer based nanometric
architectures have emerged that can potentially solve the trans-
dermal delivery challenge.14,15 New developments have high-
lighted polymeric nanoparticles as possible drug delivery
devices for transdermal applications by accumulation, e.g., by
improving drug penetration, taking advantage of the reservoir
function in hair follicle (HF) openings, and by performing con-
trolled release.16,17 Of all the polymeric nanoparticles, nano-
gels (NGs) have gained the most attention. NGs are aqueous
dispersions of hydrogel particles in the nanometer range and
are formed with physically or chemically crosslinked polymer
network chains.18,19 NGs have already shown many interesting
intrinsic properties, such as high water content, soft nature,
flexibility, cell and tissue compatibility, and excellent water
dispersion/solubility.
When responsive polymers are used as building blocks for
NGs, these architectures can largely respond to external factors
like temperature,20 pH,21 light,22 electrical fields,9 etc., and
change their properties as a result.23 Particularly, thermo-
responsive polymers react to enviromental changes, i.e.,
temperature can change NG properties like hydrophobic/
hydrophilic balance, softness, size, and aggregation behavior,
which are all important for biomedical applications.24–26
Because of these changes upon enviromental triggers, the
drug encapsulation and release profiles of these systems have
been well studied as drug delivery devices.18,27,28 The same
concept has already been explored for transdermal drug deliv-
ery systems,21,29–32 but, to the best of our knowledge, no study
of a temperature dependent dermal uptake of thermorespon-
sive NGs has been reported yet. Nevertheless, optimization of
synthetic methodologies that allow a reproducible synthetic
control over size, shape, and physicochemical properties is
still a milestone in the synthesis of NGs.22,33,34
More precisely, the development of NGs for transdermal
applications calls for an optimization of synthetic routes that
enable control over the nanoparticle properties like size, flexi-
bility, deformability, and drug loading capacity. Among the
typical methodologies for preparing NGs, free radical dis-
persion/precipitation polymerization is particularly attractive
because it yields particles with sizes between 0.1 to 15 μm in a
single reaction step.25,35,36 Therefore this methodology was utilized
in this work to synthesize tNGs through a free radical polymeri-
zation of acrylated dendritic polyglycerol (dPG-Ac) and ethylene
glycol methacrylates, as shown in Fig. 1a and Table S1 (ESI†).
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dPG-Ac as a water soluble crosslinker and di(ethylene glycol)
methyl ether methacrylate (DEGMA) and oligo ethylene glycol
methacrylate (OEGMA475) as the thermoresponsive mono-
mers, were chosen, respectively, as building blocks to combine
their inherent multifunctionality, responsiveness, and bio-
compatibility.37–41
It is diﬃcult to predict the size at which a particle will pass
the skin barrier. It is known from the literature that the
biggest particle size is 10 nm for not easily deformable
materials and higher (above 50 nm) for soft and flexible par-
ticles.42 Therefore we aimed for tNGs in the size range of
50–200 nm and with a VPTT of 36–40 °C, slightly higher than
the temperature of healthy skin.43 It is expected that such
tNGs would not easily penetrate the lipophilic SC barrier
below their transition temperature due to their high hydrophi-
licity. But once the tNGs surpasse their VPTT, for instance in
inflamed skin areas, their lipophilicity will change from a
hydrophilic to a hydrophobic state. This change is expected
to improve the interaction with the hydrophobic structures
of the SC that would result in a better penetration in the skin.
To achieve tNGs with these requirements, we fine tuned
their size and VPTT by varying the synthetic parameters like
sodium dodecyl sulphate (SDS) feed, dPG-Ac feed, monomer
ratio, and dPG-Ac functionalization degree (Fig. 1b–e,
Table S1, ESI†).
The size of the tNGs was tuned first by modifying the SDS
feed prior to polymerization. As expected,44 increasing the SDS
feed from 1 to 16 mg decreased the tNG’s size from 170 to
112 nm, respectively. VPTT showed a slightly decreasing
tendency with the SDS feed increasing. With a size close to
150 nm and a transition temperature above 30 °C, a value of
2 mg SDS feed was therefore set as the first fixed parameter
(Fig. 1b).
It was found that increasing the dPG-Ac feed ratio eﬀec-
tively decreased the tNG diameter within the range of
272–97 nm (Fig. 1c). This was attributed to the higher cross-
linker density within the network, which consequentially
decreased the primary chain length. Moreover, the greater
degree of crosslinking may have provoked an increase in
the polymer network’s elastic tension, which conspicuously
reduced the swelling of the NGs and, as a result, their hydro-
dynamic diameter. The dPG-Ac feed ratio within the tNGs was
confirmed by 1H-NMR spectroscopy, which showed an increase
in the ethylene glycol chain proton signals for the tNGs with a
lower dPG-Ac feed ratio (Fig. S1, ESI†). This result indicated a
positive correlation of the crosslinker composition inside the
tNG with the dPG-Ac feed. Moreover, VPTT was also aﬀected by
the dPG-Ac feed. Since VPTT depends on the balance between
hydrophobicity and hydrophilicity within the tNG, increasing
the dPG-Ac composition also increased the network’s hydro-
philicity. This caused the phase transition temperature to rise
until a dPG-Ac feed ratio of 55 wt%, at which point the VPTT
was no longer measurable (Fig. 1c). A compromise between a
size below 200 nm and a low transition temperature around
40 °C was found at a dPG-Ac feed ratio of 10 wt%.
Varying the monomer mole fraction (χDEGMA) had a big
influence on the polydispersity of the yielded tNGs. Copoly-
merization with dPG-Ac (7% acrylation degree) only showed an
acceptable polydispersity value when monomer mol fractions
near 1 were used (χDEGMA = 1, PDI = 0.07) (Fig. 1d). As a result,
the synthetic control over tNG’s VPTT could be investigated by
tailoring the hydrophobic/hydrophilic balance on the macro-
molecular crosslinker with its acrylation degree.
As expected,35 when the functionalization degree of the
dPG-Ac (4–12%) increased, the size of the particles tended to
decrease from 165 to 146 nm. Moreover, when the crosslinker’s
degree of functionalization rose, the VPTT moderately des-
cended from 42 to 37 °C. A higher dPG-Ac functionalization
degree increased the network’s hydrophobicity and caused the
VPTT to slightly drop (Fig. 1e). In summary, a dPG acrylation
degree of around 10% was found to be ideal for temperature-
dependant skin penetration purposes and yielded tNGs with
sizes below 200 nm and convenient transition temperatures
between 37–42 °C.
The four screened parameters were used to tune the size and
transition temperatures of the synthesized thermoresponsive
system in order to allow the design of tNGs that would facilitate
the shuttling of active compounds across the skin barrier.
Temperature diﬀerences between healthy and diseased skin or
external heating were expected to improve skin penetration of
tNGs due to the change in physicochemical properties at
diﬀerent temperatures.
Consequently, rhodamine B (Rhd) labelled tNGs were syn-
thesized to be trackable in ex vivo human skin experiments.
The above-mentioned parameters were applied for the Rhd
labelled tNGs synthesis: 2 mg as SDS feed, χDEGMA = 1, 10 wt%
Fig. 1 (a) General scheme of the nanogeliﬁcation reaction and para-
meters screened for size and VPTT tuning: (b) SDS feed, (c) dPG-Ac
feed, (d) monomer ratio, and (e) dPG-Ac functionalization degree. All
data are shown in detail in Table S1 (ESI†).
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dPG-Ac feed, and 9% dPG-Ac acrylation degree. A post-syn-
thetic labelling of tNG with Rhd through ester formation coup-
ling reaction only yielded low conjugation eﬃciencies and NGs
with dye ratios in the sub µmolRhd/mgNG range (data not
shown). Therefore, a 2/8 mixture of dye labelled dPG-Ac (Rhd-
dPG-Ac) and unlabelled dPG-Ac was employed to introduce the
dye with a total crosslinker feed value of 10 wt%. Adding an
extra crosslinking unit like Rhd-dPG-Ac, the system’s hydro-
philicity was increased. Consequently, the size for Rhd-tNG
(NG20) changed from the expected 150 to 80 nm. The VPTT,
however, did not significantly diﬀer (36 °C) and remained in
the desired range when only 2 wt% feed of the hydrophilic
crosslinker Rhd-dPG-Ac was used (ESI†). Moreover reversible
thermoresponsive behavior was demonstrated when NG20 was
analysed via turbidimetry (Fig. S2†). As a negative control for
skin internalization experiments, a non-thermoresponsive NG
was synthesized by mainly modifying the cross-linking content
(ESI†). By employing only Rhd-dPG-Ac as the crosslinker and a
monomer ratio of χDEGMA = 0.91, NG21 was obtained with a
size of 78 nm, which was comparable to NG20 (Table S1, ESI†),
but did not show a phase transition below 75 °C (Fig. 2c). Both
NGs were intensively characterized (Fig. 2 and ESI†). The
characteristic monomer and crosslinker peaks as well as the
lack of vinyl signals in the 1H-NMR spectra revealed a complete
polymerization. The sizes were investigated with dynamic light
scattering (DLS), transmission electron microscopy (TEM), and
liquid/fluid atomic force microscopy (AFM) techniques, which
gave correlative sizes as well as a low degree of dispersion
(Fig. 2d–g, Fig. S3, ESI†). Dye concentration was determined by
UV-Vis spectroscopy which yielded values of 8.26 and
68.3 mmolRhd/mgNG for NG20 and NG21, respectively.
The bigger dye amount per NG in the non-thermoresponsive
NG was obtained due to the use of only Rhd-dPG-Ac as
crosslinker.
To test the tNGs’ biocompatibility, the cytotoxicity in a
human keratinocyte cell line (HaCaT) and fibroblast cell line
(NIH3T3) was analyzed. Metabolic activity (MTS assay) and
real time cell analysis (RTCA) showed IC50 values between 10
and 33 mg mL−1, respectively (Fig. S4, ESI†). These high toler-
able doses demonstrate tNGs’ great cytocompatibility and
potential for topical applications. Cell uptake experiments in
A549 cell line revealed an endosomal uptake pathway on
cancer cells (Fig. S5, ESI†).
Rhd-tNG (NG20) was employed to study temperature-depen-
dent transdermal penetration into full-thickness excised
human skin after topical application. Non-thermoresponsive
Rhd-NG (NG21) was used as the negative control. Both NG
samples were applied on the surface of the excised human
skin at the same dye concentration of 41.3 mM. The skin pene-
tration profile was analyzed on skin sections after 4 hours
incubation at two diﬀerent temperatures, below (4 °C) and
above (37 °C) the VPTT of NG20. Dye fluorescence intensity
was observed on the skin surface and in SC of all analyzed
cryosections, regardless of the type of NGs and the incubation
temperature (Fig. 3). Similar skin penetration profiles were
also found in our previous studies with more rigid nano-
particles like polystyrene and silica oxide.45,46 However, fluo-
rescence intensity was also detected in the epidermis, that
indicated the presence of tNGs in viable skin (Fig. 3b). Mean
fluorescence intensity (MFI) analysis confirmed that there were
no significant diﬀerences observed in the analyzed SC sections
between the thermoresponsive and non-thermoresponsive
NGs, regardless of the incubation temperature. On the con-
trary, higher fluorescence intensities were measured in viable
skin for the NG20 samples incubated at 37 °C in comparison
to the same NGs at 4 °C incubation temperature and NG21
samples at 37 °C (Fig. 3). Even though diﬀusion processes
might be slowed down at 4 °C, there were no remarkable diﬀer-
ences observed between MFI values of NG20 and NG21 in the
viable skin regions. These observations reflect the tempera-
ture-dependent conformational changes in the tNGs and
the resultant alteration of their physicochemical properties
like increased hydrophobicity, which allowed them to
penetrate the SC and translocate to the epidermis. Accumu-
lation of NGs in the HF canal was also investigated.
Higher fluorescence intensity was observed in the HF canal for
NG20 incubated at 37 °C than for the same sample incubated
at 4 °C (Fig. S6, ESI†). No statistical analysis could be per-
formed because of the low amount of HF in the analyzed skin
sample.
Fig. 2 (a) Images of thermoresponsive (NG20, left) and non thermo-
responsive (NG21, right) NGs at two temperatures, below (25 °C) and
above (40 °C) the VPTT of NG20. DLS temperature-trend measurements
of NG20 (b) and NG21 (c). TEM (d and f) and AFM (e and g) images of
NG20 and NG21.
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Conclusions
The dispersion/precipitation polymerization methodology
proved to be robust for the synthesis of tNGs. Sizes and VPTTs
were modified by changing the surfactant concentration (SDS
feed), crosslinker (dPG-Ac) acrylation degree and feed, and
OEGMA feed ratio. By varying the studied synthetic para-
meters, Rhd labeled NGs were synthesized with required sizes
and VPTT. Application of tNGs on human skin explants
showed, for the first time, a temperature-dependent inter-
action of soft nanoparticles with the skin barrier and HF
canals. Dye labeled NGs easily penetrated into SC and
occasionally in the epidermis. The thermoresponsive nanogel
NG20 had a better penetration in the epidermis than the non-
thermoresponsive one when incubation temperatures were
above the VPTT. These first experiments strengthen the ration-
ale for further development of tNGs for applications in
dermatotherapy and transdermal drug delivery. While in this
study we investigated the influence of temperature on the skin
penetration profile of tNGs, in ongoing studies, we are investi-
gating tNGs loaded with non-covalently bound dyes and drugs
in order to evaluate the influence of thermal triggers on the
tNGs release properties.
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